Can-Fite BioPharma Ltd. Sponsored ADR
(NYSE Amex Equities : CANF)

( )
CANF PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.39%79.461.2%$549.41m
AMGNAmgen Inc.
0.00%186.511.2%$522.70m
GILDGilead Sciences, Inc.
-0.35%71.210.9%$512.46m
BIIBBiogen Inc.
0.00%296.861.2%$436.96m
NKTRNektar Therapeutics
0.69%58.575.6%$387.55m
SRPTSarepta Therapeutics, Inc.
1.44%155.9016.6%$329.95m
VRTXVertex Pharmaceuticals Incorporated
0.00%157.631.9%$249.95m
REGNRegeneron Pharmaceuticals, Inc.
0.91%340.002.6%$246.97m
ILMNIllumina, Inc.
0.00%287.653.5%$192.25m
AAgilent Technologies, Inc.
0.00%62.801.5%$181.08m
BLUEBluebird Bio, Inc.
1.04%185.0015.7%$152.52m
BMRNBioMarin Pharmaceutical Inc.
0.00%98.344.4%$150.53m
ALXNAlexion Pharmaceuticals, Inc.
0.00%124.522.0%$145.54m
EXASExact Sciences Corporation
0.00%69.3325.5%$143.19m
INCYIncyte Corporation
1.39%74.452.5%$127.36m

Company Profile

Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer. Can-Fite BioPharma was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach Tikva, Israel.